SGLTi, Hepatic Glucose Production and Ketogenesis

NCT05960656 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Empagliflozin 25 MG
OTHER: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]